Hyperuricemia and gout closely associated with development of diabetes Jacinthlyn Sylvia6 May 2023 10:00 AM ISTA new study published in Current Diabetes Reports suggests that when compared to people who are healthy, people with hyperuricemia and gout are more...
Study suggests association between periodontitis and increased blood uric acid levels Medha Baranwal10 April 2023 8:00 PM ISTChina: In a recent review published in BMC Oral Health, researchers have suggested an association between periodontitis and increased blood uric acid...
Zydus Lifesciences recalls over 55000 bottles of gout drug Colchicine in US Ruchika Sharma27 March 2023 12:15 PM ISTThe affected lot is manufactured by Ahmedabad-based Zydus Lifesciences and marketed in the US by New Jersey-based Zydus Pharmaceuticals (USA) Inc.
Dapagliflozin benefits heart failure patients regardless of their gout status: JAMA Medha Baranwal27 Feb 2023 10:30 AM ISTUK: A post hoc analysis of 2 trials revealed that dapagliflozin's benefit is consistent in heart failure (HF) patients irrespective of gout. The use...
Which antihypertensive drugs are associated with gout and hyperuricemia related adverse effects? Jacinthlyn Sylvia9 Feb 2023 8:00 PM ISTResearchers have found in a new study that antihypertensive drugs like potassium-sparing diuretics, calcium channel blockers and losartan are...
Pegloticase response rates higher when co-treated with immunomodulating therapy in gout patients Dr Supreeth D R11 Dec 2022 8:00 PM ISTPatients with uncontrolled/refractory gout have heavy disease burden, but few treatment options. Pegloticase lowers serum urate (SU), but anti-drug...
Is metabolic syndrome a modifiable risk factor for gout? Dr. Kamal Kant Kohli30 Nov 2022 8:00 PM ISTIn a study published in Arthritis & Rheumatology that included nearly 1.3 million men aged 20-39 years who participated in three serial health...
Febuxostat demonstrates efficacy and renal safety in patients with gout and CKD Dr Supreeth D R23 Nov 2022 8:00 PM ISTPeiyu Zhang et al conducted a study to explore the efficacy and renal safety of febuxostat in gout and stage 2-4 chronic kidney disease (CKD) and...
Use of Allopurinol Associated with Lower Risk of First Coronary Event among gout patients Dr. Kamal Kant Kohli16 Nov 2022 9:30 AM ISTSweden: Gout patients who take allopurinol have a lower risk of developing their first acute coronary syndrome (ACS), according to research published...
Allopurinol tied to less mortality compared to febuxostat among patients with CVD Aditi4 Nov 2022 8:00 PM ISTChina: A study published in the Frontiers in Pharmacology mentioning a comparison between Allopurinol and Febuxostat has concluded that allopurinol...
Probiotic Supplementation: A complete boon for inflammatory arthritis Aditi24 Oct 2022 8:00 PM ISTCHINA: A recent study has proven the beneficial effect of probiotics in improvising eight forms of inflammatory arthritis, namely Hyperuricemia and...
Allopurinol fails to improve CV outcomes in ischemic heart disease patients: ALL-HEART trial Dr.Niharika Harsha B12 Oct 2022 8:30 PM ISTA recent study found that allopurinol did not improve the primary outcomes in cardiovascular patients aged 60 years or older with ischemic heart...
